CIK: 1212229 - Address: C/o Panacos Pharmaceuticals, Inc., 134 Coolidge Avenue, Watertown, MA 02472
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/5/05 16:53
1/3/05
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-918.040-1-371D
12/30/04 19:00
12/28/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2717.810-2-392D
12/23/04 15:52
12/21/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2717.900-2-482D
12/16/04 17:51
12/14/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2718.050-2-502D
12/14/04 16:17
12/10/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2717.720-2-502D
11/30/04 17:33
11/29/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2617.450-2-502D
11/29/04 20:00
11/24/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2416.000-2-502D
11/19/04 14:54
11/17/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2617.050-2-502D
11/17/04 12:16
11/12/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2516.750-2-502D
11/10/04 07:11
11/5/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2516.650-2-472D
11/2/04 16:39
10/29/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2415.680-2-502D
10/26/04 20:41
10/22/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2516.700-2-502D
10/19/04 17:50
10/15/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2516.620-2-502D
10/12/04 20:59
10/7/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-2617.650-2-502D
10/6/04 17:41
10/4/04
EPIXEpix Pharmaceuticals, Inc.HealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-3020.000-2-502D
6/3/04 19:49
6/1/04
EPIXEpix Medical IncHealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-6325.060-3-503D
5/28/04 17:59
5/26/04
EPIXEpix Medical IncHealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.dm-1325.050-1-630D
5/5/04 18:21
5/3/04
EPIXEpix Medical IncHealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-6325.000-3-503D
4/26/04 19:14
4/22/04
EPIXEpix Medical IncHealthDiagnIn Vitro & In Vivo DiagnosticMarshall Peyton JMAOSVP,Fin.S.d-6325.150-3-503D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact